D3 FASTPOINT L-DFA INFLUENZA A/INFLUENZA B VIRUS IDENTIFICATION KIT

Antisera, Cf, Influenza Virus A, B, C

DIAGNOSTIC HYBRIDS, INC.

The following data is part of a premarket notification filed by Diagnostic Hybrids, Inc. with the FDA for D3 Fastpoint L-dfa Influenza A/influenza B Virus Identification Kit.

Pre-market Notification Details

Device IDK092882
510k NumberK092882
Device Name:D3 FASTPOINT L-DFA INFLUENZA A/INFLUENZA B VIRUS IDENTIFICATION KIT
ClassificationAntisera, Cf, Influenza Virus A, B, C
Applicant DIAGNOSTIC HYBRIDS, INC. 1055 EAST STATE STREET SUITE 100 Athens,  OH  45701
ContactRonald H Lollar
CorrespondentRonald H Lollar
DIAGNOSTIC HYBRIDS, INC. 1055 EAST STATE STREET SUITE 100 Athens,  OH  45701
Product CodeGNW  
CFR Regulation Number866.3330 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-09-18
Decision Date2009-10-21
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
30014613330806 K092882 000
30014613330790 K092882 000
30014613330783 K092882 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.